Understanding the epigenetic syntax for the genetic alphabet in the kidney.

The cells in a human body have identical DNA sequences, yet the body has >200 cell types with different phenotypes. The basis for this nongenetic cellular memory, which records developmental and environmental cues, is epigenetics. The epigenome includes covalent modifications of the DNA and its associated proteins and defines DNA accessibility to the transcriptional machinery. Notably, the epigenome has emerged as an important mediator of the long-term programming effect of environmental exposure, and multiple lines of evidence point to the epigenome as an important missing link in our understanding of CKD development. For example, recent studies identified epigenetic differences in the enhancer regions of fibrosis-related genes in diseased human kidney samples. Furthermore, chromatin profiling and epigenome analysis are powerful tools for annotating gene regulatory regions that can be harnessed to interpret disease-causing polymorphisms for complex traits such as CKD. This review highlights the results of studies investigating the renal epigenome and discusses the significance of these findings and future directions in the context of novel diagnostic and treatment strategies for CKD.

[1]  Raymond K. Auerbach,et al.  A User's Guide to the Encyclopedia of DNA Elements (ENCODE) , 2011, PLoS biology.

[2]  C. Thompson,et al.  Rethinking the regulation of cellular metabolism. , 2011, Cold Spring Harbor symposia on quantitative biology.

[3]  K. Suszták,et al.  Fetal environment, epigenetics, and pediatric renal disease , 2011, Pediatric Nephrology.

[4]  Benjamin Tycko,et al.  Allele-specific DNA methylation: beyond imprinting. , 2010, Human molecular genetics.

[5]  David R. Kelley,et al.  Long noncoding RNAs regulate adipogenesis , 2013, Proceedings of the National Academy of Sciences.

[6]  Zhiping Weng,et al.  Paternally Induced Transgenerational Environmental Reprogramming of Metabolic Gene Expression in Mammals , 2010, Cell.

[7]  R. Kalluri,et al.  Methylation determines fibroblast activation and fibrogenesis in the kidney , 2010, Nature Medicine.

[8]  R. Deberardinis,et al.  Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.

[9]  Wing Hong Wong,et al.  Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks. , 2012, Developmental cell.

[10]  M. Skinner,et al.  Environmental epigenetics and phytoestrogen/phytochemical exposures , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[12]  M. Skinner,et al.  Epigenetic transgenerational inheritance of vinclozolin induced mouse adult onset disease and associated sperm epigenome biomarkers. , 2012, Reproductive toxicology.

[13]  B. Brenner,et al.  Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction. , 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  David Z. Chen,et al.  Architecture of the human regulatory network derived from ENCODE data , 2012, Nature.

[15]  I. Mannaerts,et al.  HDAC inhibitors in experimental liver and kidney fibrosis , 2013, Fibrogenesis & tissue repair.

[16]  Julie Herbstman,et al.  Prenatal environmental exposures, epigenetics, and disease. , 2011, Reproductive Toxicology.

[17]  William Stafford Noble,et al.  Integrative annotation of chromatin elements from ENCODE data , 2012, Nucleic acids research.

[18]  B. Zinman,et al.  Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. , 2011, Archives of internal medicine.

[19]  S. Henikoff,et al.  DNA demethylation by DNA repair. , 2009, Trends in genetics : TIG.

[20]  Nicholette D. Palmer,et al.  Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African Americans , 2011, PLoS genetics.

[21]  Amit Verma,et al.  Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development , 2013, Genome Biology.

[22]  Katalin Susztak,et al.  Fine tuning gene expression: the epigenome. , 2010, Seminars in nephrology.

[23]  Manolis Kellis,et al.  Interplay between chromatin state, regulator binding, and regulatory motifs in six human cell types , 2013, Genome research.

[24]  John J Rossi,et al.  MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors , 2007, Proceedings of the National Academy of Sciences.

[25]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[26]  Nathan C. Sheffield,et al.  The accessible chromatin landscape of the human genome , 2012, Nature.

[27]  D. Bachvarov,et al.  Histone Deacetylase (HDAC) Activity Is Critical for Embryonic Kidney Gene Expression, Growth, and Differentiation* , 2011, The Journal of Biological Chemistry.

[28]  C. Sapienza,et al.  DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy , 2011, Epigenetics.

[29]  Reid F. Thompson,et al.  Experimental Intrauterine Growth Restriction Induces Alterations in DNA Methylation and Gene Expression in Pancreatic Islets of Rats* , 2010, The Journal of Biological Chemistry.

[30]  R. Mirmira.  Faculty Opinions recommendation of Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. , 2008 .

[31]  S. Henikoff.  ENCODE and our very busy genome , 2007, Nature Genetics.

[32]  L. Mirny,et al.  Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data , 2013, Nature Reviews Genetics.

[33]  Michael Q. Zhang,et al.  Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications , 2010, Nature Biotechnology.

[34]  Timothy J. Durham,et al.  "Systematic" , 1966, Comput. J..

[35]  George M Weinstock,et al.  ENCODE: more genomic empowerment. , 2007, Genome research.

[36]  M. Gerstein,et al.  What is a gene, post-ENCODE? History and updated definition. , 2007, Genome research.

[37]  Y. Ko,et al.  Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease? , 2013, Seminars in nephrology.

[38]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[39]  Timothy J. Durham,et al.  Combinatorial Patterning of Chromatin Regulators Uncovered by Genome-wide Location Analysis in Human Cells , 2011, Cell.

[40]  R. Roeder,et al.  Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia , 2008, The Journal of Experimental Medicine.

[41]  R. Natarajan,et al.  The role of epigenetics in the pathology of diabetic complications. , 2010, American journal of physiology. Renal physiology.

[42]  T. Mikkelsen,et al.  The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.

[43]  A. Feinberg,et al.  Regulated Noise in the Epigenetic Landscape of Development and Disease , 2012, Cell.